AzTrials
AzTrials

Performance Enhancing Product UseNCT06112210

Effect of Hyperbaric Oxygen Therapy

A study testing HBOT group and CON group in people with Performance Enhancing Product Use and Physical Fitness, run by University Medical Centre Ljubljana at 1 site in Serbia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this tudy will be to investigate the effects of a single session of hyperbaric oxygen therapy (HBOT) on recovery and performance after a football match in elite youth football players. Read more about this study

Who is it for?
Ages 16 to 18 years, men onlyHealthy volunteers can take part
What is being tested?
HBOT group and CON group
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
20 participants
Where
1 siteSerbia
Study dates
20 May 2023to 6 Jun 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 18 years
  • Men only
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • football player
  • free of injuries
  • free of medical conditions contraindicated by hyperbaric oxygen therapy (HBOT)
  • written parental consent

Who cannot join

  • pre-existing injuries or medical conditions that are contraindicated by hyperbaric oxygen therapy (HBOT)
  • participation in severe physical activity within 24 hours before the study
  • participants who do not comply with the requirement to abstain from breakfast, caffeine, and alcohol prior to the first blood collection
  • an active respiratory illness, such as a cold, at the time of the study

Trial locations and contacts

1 site in 1 country.

Serbia1 site
  • Hyperbaric center Subotica

    Subotica

Other trials in Serbia

About this study

Official title: Effect of Hyperbaric Oxygen Therapy Has no Acute Effects on Recovery and Performance After a Football Match

The goal of this tudy will be to investigate the effects of a single session of hyperbaric oxygen therapy (HBOT) on recovery and performance after a football match in elite youth football players.

The main questions this study will aim to answer are:

Read more

Will a single session of HBOT improve recovery parameters such as biochemical markers and physical fitness in elite youth football players after a football match? Will a single session of HBOT enhance the performance of elite youth football players after a football match?

Participants in this study will include twenty elite youth male football players. They will be randomly assigned to either the HBOT group or the control group. All participants will undergo evaluations for biochemical parameters, physical fitness tests, and the Hooper Index (HI) at multiple time points: before the match, at the end of the match, one hour after the HBOT session, and 12 hours after the HBOT session.

In the HBOT group, participants will receive 100% oxygen under elevated pressure in a hyperbaric chamber for a duration of 70 minutes immediately after the football match. Meanwhile, the control group will be exposed to normal atmospheric pressure.

Biochemical analysis will involve collecting blood samples to measure markers such as myoglobin, creatine kinase, lactate dehydrogenase, alanine aminotransferase, and aspartate aminotransferase. Physical fitness tests will include vertical jump height measurements (squat jump, countermovement jump, and countermovement jump with arm swing) and linear speed assessments at various distances (5 m, 10 m, and 20 m). The Hooper Index (HI) will be used for subjective assessment of fatigue and well-being.

This study aims to provide insights into the potential benefits of HBOT as a recovery strategy for elite youth football players and its impact on performance in the future.

Being tested
HBOT group, CON group
Keywords
hyperbaric chamber, football, recovery, hyperbaric oxygen therapy, performance, fatigue
Medical subject headings
Fatigue

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • HBOT groupOther

    The HBOT will be performed in a Barox HBOT chamber (Yaklasim Makina San. Ve Tic. Ltd. Sti). Participants will be taken to the chamber immediately after the football match, where they will sit in individual chairs, and oxygen will be delivered through individual masks. The HBOT group will be exposed to 100% oxygen at 2.2 ATA (atmospheres absolute). Session will last 70 minutes.

  • CON groupOther

    Also called Control, Placebo

    The placebo protocols will be performed in a Barox HBOT chamber (Yaklasim Makina San. Ve Tic. Ltd. Sti). Participants will be taken to the chamber immediately after the football match, where they will sit in individual chairs, and oxygen will be delivered through individual masks. The CON group will be exposed to normobaric ambient pressure (1 ATA). The session will last 70 minutes.

Study groups in NCT06112210
Study groupRoleWhat they receive
HBOT groupExperimentalNot described
Receives: Other: HBOT group
CON groupPlacebo comparatorNot described
Receives: Other: CON group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Myoglobin

    Measure of myoglobin concentration in blood. Myoglobin will be determined using Siemens IMMULITE 1000 (Siemens Healthcare Diagnostics, UK).

    Measured: baseline, 3 hours, 5 hours, 24 hours

  2. Creatine kinase

    Measure of creatine kinase concentration in blood. It will be analyzed using a biochemistry analyzer (A25 Biosystems Chemistry Analyzer).

    Measured: baseline, 3 hours, 5 hours, 24 hours

  3. Lactate dehydrogenase

    Measure of lactate dehydrogenase concentration in blood. It will be analyzed using a biochemistry analyzer (A25 Biosystems Chemistry Analyzer).

    Measured: baseline, 3 hours, 5 hours, 24 hours

  4. Alanine aminotransferase

    Measure of alanine aminotransferase concentration in blood. It will be analyzed using a biochemistry analyzer (A25 Biosystems Chemistry Analyzer).

    Measured: baseline, 3 hours, 5 hours, 24 hours

  5. Aspartate aminotransferase

    Measure of aspartate aminotransferase concentration in blood. It will be analyzed using a biochemistry analyzer (A25 Biosystems Chemistry Analyzer).

    Measured: baseline, 3 hours, 5 hours, 24 hours

Secondary outcomes (6)
  1. Squat jump

    Measure of a squat jump height in cm. The squat jump will be performed in a semi-squat position with the knees bent at 90 degrees and the arms resting on the hips. Participants will hold this stance for one to three seconds before executing a maximal vertical jump.

    Measured: baseline, 3 hours, 5 hours, 24 hours

  2. Countermovement jump

    Measure of a countermovement jump height in cm. It will be evaluated with participants standing straight up, distributing their weight equally over both feet. The arms will be secured to the hips to prevent their influence on jump height. Participants will then squat down to a 90-degree flexion and execute a maximal vertical jump without pausing during the change of direction.

    Measured: baseline, 3 hours, 5 hours, 24 hours

  3. Countermovement jump with arm swing

    Measure of a countermovement jump with arm swing height in cm. It will be evaluated with participants standing straight up, distributing their weight equally over both feet. During the jump, participants will have the freedom to move their arms.

    Measured: baseline, 3 hours, 5 hours, 24 hours

  4. 5 meter linear speed

    Measure of 5 meter linear speed. The Witty photocell system (Witty, System, Microgate, Bolzano, Italy) will be utilized to evaluate performance. These photocells will be positioned 0.4 meters above the ground and will provide measurements with an accuracy of 0.001 meters per second.

    Measured: baseline, 3 hours, 5 hours, 24 hours

  5. 10 meter linear speed

    Measure of 10 meter linear speed. The Witty photocell system (Witty, System, Microgate, Bolzano, Italy) will be utilized to evaluate performance. These photocells will be positioned 0.4 meters above the ground and will provide measurements with an accuracy of 0.001 meters per second.

    Measured: baseline, 3 hours, 5 hours, 24 hours

  6. 20 meter linear speed

    Measure of 20 meter linear speed. The Witty photocell system (Witty, System, Microgate, Bolzano, Italy) will be utilized to evaluate performance. These photocells will be positioned 0.4 meters above the ground and will provide measurements with an accuracy of 0.001 meters per second.

    Measured: baseline, 3 hours, 5 hours, 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Nov 2023
  2. Study start20 May 2023
  3. Primary completion4 Jun 2023
  4. Study completion6 Jun 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06112210
Sponsor's protocol ID
HBstudy
Status last verified
Oct 2023
First submitted
18 Oct 2023
Last updated
1 Nov 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing HBOT group and CON group in people with Performance Enhancing Product Use and Physical Fitness, run by University Medical Centre Ljubljana at 1 site in Serbia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Serbia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Myoglobin (time frame: baseline, 3 hours, 5 hours, 24 hours). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Nov 2023; AzTrials last refreshed its copy on 28 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in